Siegfried Holding AG (SIX: SFZN) was awarded Prime Status in the sustainability rating carried out by Institutional Shareholder Services Inc. (ISS), a leading global proxy advisory firm. This status is awarded only to companies that fulfil demanding criteria and achieve a high sustainability performance. With this rating, Siegfried belongs to the top 10 percent of all life science companies rated by ISS. Accordingly, Siegfried Holding AG’s shares and bonds meet responsible investment criteria.
Wolfgang Wienand, Siegfried CEO: "As a company with a long tradition and entrepreneurial history, the Siegfried Group has always taken its responsibility towards people and the environment seriously. Consequently, sustainability and integrity are two of our company’s core values that guide our actions and represent the foundation of our success. ISS’ Prime Label confirms that we are on the right track. And we shall continue on this track – in the interest of our employees, customers, investors and other stakeholders.”
Consideration of Reporting Requirements
Following the introduction of sustainability reporting several years ago on the basis of the world’s most widely used and trusted Global Reporting Initiative (GRI) guidelines, Siegfried considered in its 2019 reporting for the first time the United Nations Organization’s Sustainable Development Goals (SDG). For this, Siegfried identified individual goals of special relevance to the company.
Reto Suter, Siegfried CFO: "By including ESG criteria in Siegfried’s corporate governance, we reduce risk and increase our company’s resilience. For shareholders, this improves our risk-reward ratio and, in the long run, will offer additional value creation potential. We are proud that ISS awarded us the Prime Label. This recognition strengthens our reputation in this important area."
Further information concerning the ISS ESG Rating and the Prime Label is available at: issgovernance.com/esg/ratings/
Dr. Reto Suter, Chief Financial Officer
Tel. +41 62 746 11 35
The Siegfried Group is a global life sciences company with sites in Switzerland, the USA, Malta, China, Germany and France. In 2019, the company achieved sales of 833.5 million Swiss francs and currently employs more than 2500 people at nine sites on three continents. Siegfried Holding AG is publicly listed on SIX Swiss Exchange (SIX: SFZN).
Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, and cartridges) for the pharmaceutical industry and provides development services.